News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Yuki Nishida: It was such an honor that I was able to introduce our recent work on p53/MDM2 and mutant p53.
Photo taken from Yuki Nishida/LinkedIn
Oct 21, 2023, 19:35

Yuki Nishida: It was such an honor that I was able to introduce our recent work on p53/MDM2 and mutant p53.

Yuki Nishida, Instructor at MD Anderson Cancer Centre, shared on LinkedIn:

“It was such an honor that I was able to introduce our recent work on p53/MDM2 and mutant p53 to David Lane, who is one of the discoverers of p53…!! What an amazing experience in the 10th International MDM2 Workshop in Tokyo! And more than that, I was selected as the best poster discussion award!
Many thanks to organizers, our lab members and my mentor Dr. Michael Andreeff!”

Yuki Nishida: It was such an honor that I was able to introduce our recent work on p53/MDM2 and mutant p53.

Source: Yuki Nishida/LinkedIn.

cancer David Lane Michael Andreeff OncoDaily Oncology p53/MDM2 Yuki Nishida
Special Coverage
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been